US HB7539 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 5 2024 - 25% progression
Action: 2024-03-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 5 2024 - 25% progression
Action: 2024-03-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Secretary of the Treasury to guarantee BioBonds in order to provide funding for loans to eligible biomedical companies and universities to carry out clinical trials approved by the Food and Drug Administration, and for other purposes.
Title
LOANS for Biomedical Research Act Long-term Opportunities for Advancing New Studies for Biomedical Research Act
Sponsors
| Rep. Brian Fitzpatrick [R-PA] | Rep. Sanford Bishop [D-GA] | Rep. Pete Sessions [R-TX] | Rep. Jill Tokuda [D-HI] |
| Rep. Adrian Smith [R-NE] | Rep. Josh Gottheimer [D-NJ] | Rep. Brendan Boyle [D-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-08 | House | Referred to the Subcommittee on Health. |
| 2024-03-05 | House | Referred to the House Committee on Energy and Commerce. |
| 2024-03-05 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/7539/all-info |
| Text | https://www.congress.gov/118/bills/hr7539/BILLS-118hr7539ih.pdf |
